Klaiman Tamar, Ianotte L G, Josephs Michael, Russell Louise B, Norton Laurie, Mehta Shivan, Troxel Andrea, Zhu Jingsan, Volpp Kevin, Asch David
University of Pennsylvania Perelman School of Medicine.
Lake Erie College of Osteopathic Medicine.
Res Sq. 2023 Jan 20:rs.3.rs-2206783. doi: 10.21203/rs.3.rs-2206783/v1.
: Heart failure (HF) is one of the most common reasons for hospital admission and is a major cause of morbidity, mortality, and increasing health care costs. The EMPOWER study was a randomized trial that used remote monitoring technology to track patients' weight and diuretic adherence and a state-of-the-art approach derived from behavioral economics to motivate adherence to the reverse monitoring technology. : The goal was to explore patient and clinician perceptions of the program and its impact on health outcomes and better understand why some patients/clinicians did better/worse than others in response to the intervention. : This was a retrospective qualitative study to understand the trial's processes, reflecting on successes and areas for improvement for future iterations of behavioral economic interventions. Many patients felt supported, and they appreciated the intervention. Many also appreciated the lottery intervention, and while it was not an incentive for enrolling for many respondents, it may have increased adherence during the study. Clinicians felt that the intervention integrated well into their workflow, but the number of alerts was burdensome. Additionally, responses to alerts varied considerably by provider, perhaps because there are no professional guidelines for alerts unaccompanied by severe symptoms. : Those interviews offer insights into the potential reasons for the study's null result and opportunities for improvements in the future. ClinicalTrials.gov Identifier: NCT02708654.
心力衰竭(HF)是住院治疗最常见的原因之一,也是发病、死亡以及医疗保健成本增加的主要原因。EMPOWER研究是一项随机试验,该试验使用远程监测技术追踪患者体重和利尿剂依从性,并采用源自行为经济学的先进方法来促使患者坚持使用反向监测技术。目标是探究患者和临床医生对该项目的看法及其对健康结果的影响,并更好地理解为何有些患者/临床医生在干预措施的作用下表现较好/较差。这是一项回顾性定性研究,旨在了解试验过程,反思行为经济干预未来迭代的成功之处和改进领域。许多患者感到得到了支持,他们对干预措施表示赞赏。许多患者也对抽奖干预表示赞赏,虽然这对许多受访者来说并非参与研究的诱因,但它可能在研究期间提高了依从性。临床医生认为该干预措施很好地融入了他们的工作流程,但警报数量过多令人负担过重。此外,不同医疗服务提供者对警报的反应差异很大,这可能是因为对于没有严重症状伴随的警报没有专业指导原则。这些访谈为研究结果无效的潜在原因以及未来改进的机会提供了见解。ClinicalTrials.gov标识符:NCT02708654。